Tissue plasminogen activator to prevent central venous access device infections: A systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis

Medicine & Life Sciences

• Upper Extremity Deep Vein Thrombosis 100%
• Tissue Plasminogen Activator 67%
• Systematic Reviews 46%
• Equipment and Supplies 37%
• Infections 30%
• Hemophilia A 17%
• Thrombosis 16%
• Child 13%
• Catheter-Related Infections 6%
• Fibrinolytic Agents 6%
• Fibrinolysin 6%
• Central Venous Catheters 6%
• Serine Proteases 5%
• Joint Diseases 5%
• Fibrin 5%
• Plastics 5%
• Glycoproteins 4%
• Autopsy 4%
• Catheters 4%
• Clinical Trials 3%
• Therapeutics 0%